Works matching IS 13960296 AND DT 2022 AND VI 35 AND IP 10
Results: 51
Thoughts on surgical excision of onychopapilloma.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15779
- By:
- Publication type:
- Article
Management of moderate‐to‐severe plaque psoriasis with biologics: A treat‐to‐target position paper.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15777
- By:
- Publication type:
- Article
Refractory folliculitis decalvans treated with biologics: Case series in 4 situations.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15778
- By:
- Publication type:
- Article
Retrospective analysis of methylprednisolone treatment alone and in combination with methotrexate in patients with extensive alopecia areata.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15776
- By:
- Publication type:
- Article
Pemphigus foliaceus triggered after inactivated SARS‐CoV‐2 vaccine: Coincidence or causal link?
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15775
- By:
- Publication type:
- Article
Pharmacological prevention strategy for capecitabine‐induced hand‐foot syndrome: A network meta‐analysis of randomized control trials.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15774
- By:
- Publication type:
- Article
Successful treatment of follicular mucinosis with low‐dose UVA1 phototherapy.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15773
- By:
- Publication type:
- Article
Efficacy of switches within the class of IL‐17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP).
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15772
- By:
- Publication type:
- Article
Recurrent condyloma acuminatum after cryotherapy plus photodynamic therapy successfully treated by local hyperthermia: A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15771
- By:
- Publication type:
- Article
Montelukast as an effective adjuvant in the treatment of moderate acne vulgaris.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15770
- By:
- Publication type:
- Article
Pemphigus vulgaris following second dose of mRNA‐(Pfizer‐BioNTech) COVID‐19 vaccine.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15769
- By:
- Publication type:
- Article
Microneedling and 5‐flurouracil can enhance the efficacy of non‐cultured epidermal cell suspension transplantation for resistant acral vitiligo.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15768
- By:
- Publication type:
- Article
Topical gabapentin 10% in the treatment of epidermolysis bullosa pruritus: A pilot, double‐blind, split‐site, randomized controlled trial.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15767
- By:
- Publication type:
- Article
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15766
- By:
- Publication type:
- Article
Methotrexate toxicity in psoriasis—A multicentric retrospective study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15765
- By:
- Publication type:
- Article
A case report of 595 nm pulsed dye laser for the prevention and management of scar developed after vascular complication of filler application.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15764
- By:
- Publication type:
- Article
Therapeutic options for perifolliculitis capitis abscedens et suffodens: A review.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15763
- By:
- Publication type:
- Article
Intralesional injection of purified protein derivative versus Candida antigen in treatment of genital warts.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15762
- By:
- Publication type:
- Article
Guselkumab as a switching strategy after anti‐TNFα, anti‐IL17, or anti‐IL12/23 therapies in moderate‐to‐severe psoriasis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15760
- By:
- Publication type:
- Article
Latest combination therapies in psoriasis: Narrative review of the literature.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15759
- By:
- Publication type:
- Article
Immunological aspects of COVID‐19‐related skin manifestations: Revisiting pathogenic mechanism in the light of new evidence.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15758
- By:
- Publication type:
- Article
Ustekinumab to guselkumab transitions: A series of 54 patients emulating the navigate trial in real life.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15757
- By:
- Publication type:
- Article
Multiresistant Mycobacterium abscessus ulcer treated with photodynamic therapy with methyl‐aminolevulinate.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15756
- By:
- Publication type:
- Article
Therapeutic management and clinical remission for patients with psoriasis and psoriatic arthritis in a specialized dermatological‐rheumatological center.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15755
- By:
- Publication type:
- Article
Concurrent bullous pemphigoid and plaque psoriasis successfully treated with Janus kinase inhibitor Baricitinib.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15754
- By:
- Publication type:
- Article
Acne care in health care providers during the COVID‐19 pandemic: A national survey.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15753
- By:
- Publication type:
- Article
Infectious complications after hyaluronic acid injections—Two case reports.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15752
- By:
- Publication type:
- Article
Brentuximab extravasation injury in a patient with mycosis fungoides with large cell transformation.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15751
- By:
- Publication type:
- Article
Dupilumab therapy following JAK inhibitor withdrawal in moderate–severe atopic dermatitis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15750
- By:
- Publication type:
- Article
Vaccine‐induced dermatomyositis following COVID‐19 vaccination.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15749
- By:
- Publication type:
- Article
Assessment of intralesional injection of botulinum toxin type A in hypertrophic scars and keloids: Clinical and pathological study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15748
- By:
- Publication type:
- Article
Dermatological adverse events under programmed cell death‐1 inhibitors as a prognostic marker in metastatic melanoma.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15747
- By:
- Publication type:
- Article
Clinical observation and analysis of skin reactions caused by COVID‐19 vaccination.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15746
- By:
- Publication type:
- Article
Clinico‐epidemiological profile and management outcome of subungual digital glomus tumor—Indian experience.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15745
- By:
- Publication type:
- Article
Author reply to Comment on "Herpes zoster in the era of COVID 19: A prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination".
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15744
- Publication type:
- Article
Successful treatment of hidradenitis suppurativa and Crohn's disease with combined guselkumab and apremilast.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15743
- By:
- Publication type:
- Article
Comment on "Herpes zoster in the era of COVID‐19: A prospective observational study to probe the association of herpes zoster with COVID‐19 infection and vaccination".
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15742
- By:
- Publication type:
- Article
Interleukin‐23 inhibitors demonstrate high effectiveness in the treatment of a real‐world cohort of 82 psoriatic patients regardless of the HLA‐Cw6 status.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15741
- By:
- Publication type:
- Article
Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15740
- By:
- Publication type:
- Article
Vulvar eczema associated with sodium‐glucose cotransport therapy.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15738
- By:
- Publication type:
- Article
Prognosis in early stage cutaneous T‐cell lymphoma treated with psoralen plus ultraviolet A irradiation and low‐dose interferon‐α: Long‐term efficacy and survival according to conventional and emerging clinical endpoints.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15737
- By:
- Publication type:
- Article
Successful treatment of metastatic fibrosarcomatous dermatofibrosarcoma protuberans with imatinib mesylate.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15736
- By:
- Publication type:
- Article
Prevalence of genital and oral human papillomavirus infection among psoriasis patients on biologic therapy.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15735
- By:
- Publication type:
- Article
Topical sucralfate for prevention of peristomal wound reaction related to percutaneous endoscopic gastrostomy in children: A randomized controlled trial.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15729
- By:
- Publication type:
- Article
Recent modalities in treatment of telogen effluvium: Comparative study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15720
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15270
- Publication type:
- Article
Postherpetic granulomatous dermatitis and herpes zoster necroticans triggered by Covid‐19 vaccination.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15707
- By:
- Publication type:
- Article
Botulinum toxin injection as a single or combined treatment with non‐cross‐linked high molecular weight and low molecular weight hyaluronic acid gel for neck rejuvenation: A randomized clinical trial.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15673
- By:
- Publication type:
- Article
Guselkumab shows high efficacy and maintenance in the improvement of response until week 48, a real‐life study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15670
- By:
- Publication type:
- Article
Psoriatic patients with a history of cancer: A real‐life experience with Apremilast treatment for 104 weeks.
- Published in:
- 2022
- By:
- Publication type:
- Product Review